172 related articles for article (PubMed ID: 18384261)
1. Helicos BioSciences.
Milos P
Pharmacogenomics; 2008 Apr; 9(4):477-80. PubMed ID: 18384261
[TBL] [Abstract][Full Text] [Related]
2. SNPs and haplotypes: genetic markers for disease and drug response (review).
Shastry BS
Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
[TBL] [Abstract][Full Text] [Related]
3. Toward the 1,000 dollars human genome.
Bennett ST; Barnes C; Cox A; Davies L; Brown C
Pharmacogenomics; 2005 Jun; 6(4):373-82. PubMed ID: 16004555
[TBL] [Abstract][Full Text] [Related]
4. SNP market view: opportunities, technologies, and products.
Wypgant M
Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
[No Abstract] [Full Text] [Related]
5. Novel technology and the development of pharmacogenetics within the pharmaceutical industry.
Gibson N; Jawaid A; March R
Pharmacogenomics; 2005 Jun; 6(4):339-56. PubMed ID: 16004553
[TBL] [Abstract][Full Text] [Related]
6. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
7. Genelex Corporation.
Coleman H; Ashcraft K
Pharmacogenomics; 2008 Apr; 9(4):469-75. PubMed ID: 18384260
[TBL] [Abstract][Full Text] [Related]
8. The use of single-nucleotide polymorphism maps in pharmacogenomics.
McCarthy JJ; Hilfiker R
Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
[TBL] [Abstract][Full Text] [Related]
9. First phase of HapMap project already helping drug discovery.
Andrawiss M
Nat Rev Drug Discov; 2005 Dec; 4(12):947. PubMed ID: 16370072
[No Abstract] [Full Text] [Related]
10. New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies.
De La Vega FM; Dailey D; Ziegle J; Williams J; Madden D; Gilbert DA
Biotechniques; 2002 Jun; Suppl():48-50, 52, 54. PubMed ID: 12083398
[TBL] [Abstract][Full Text] [Related]
11. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics using Luminex® xMAP® technology: a method for developing a custom multiplex single nucleotide polymorphism mutation assay.
Spierings G; Dunbar SA
Methods Mol Biol; 2013; 1015():115-26. PubMed ID: 23824852
[TBL] [Abstract][Full Text] [Related]
13. Single-molecule DNA sequencing technologies for future genomics research.
Gupta PK
Trends Biotechnol; 2008 Nov; 26(11):602-11. PubMed ID: 18722683
[TBL] [Abstract][Full Text] [Related]
14. Advances in sequencing technology.
Chan EY
Mutat Res; 2005 Jun; 573(1-2):13-40. PubMed ID: 15829235
[TBL] [Abstract][Full Text] [Related]
15. Solexa Ltd.
Bennett S
Pharmacogenomics; 2004 Jun; 5(4):433-8. PubMed ID: 15165179
[TBL] [Abstract][Full Text] [Related]
16. 454 life sciences: illuminating the future of genome sequencing and personalized medicine.
Patrick K
Yale J Biol Med; 2007 Dec; 80(4):191-4. PubMed ID: 18449390
[No Abstract] [Full Text] [Related]
17. DxS Ltd.
Little S
Pharmacogenomics; 2003 Jan; 4(1):97-101. PubMed ID: 12517290
[TBL] [Abstract][Full Text] [Related]
18. Rubicon Genomics, Inc.
Langmore JP
Pharmacogenomics; 2002 Jul; 3(4):557-60. PubMed ID: 12164778
[TBL] [Abstract][Full Text] [Related]
19. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?
Lango H; Weedon MN
J Intern Med; 2008 Jan; 263(1):16-27. PubMed ID: 18088250
[TBL] [Abstract][Full Text] [Related]
20. Pyrosequencing AB.
McNeely T
Pharmacogenomics; 2003 Mar; 4(2):217-21. PubMed ID: 12605556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
